← Back to headlines
Inhibrx Stock Rises After Stifel Issues 'Buy' Rating
Inhibrx shares gained value after Stifel analysts issued a new 'Buy' rating for the company, based on the performance of its lead assets.
8 Apr, 16:10 — 8 Apr, 16:10
Sources
Showing 1 of 1 sources
Related Stories
Hawaii Doctor Convicted of Attempted Murder on Cliffside Hike
1h ago
DeCarlos Brown Jr. Deemed Incapable of Standing Trial in Iryna Zarutska Murder Case
1h ago
DeCarlos Brown Jr. Deemed Incapable of Standing Trial in Iryna Zarutska Murder Case
1h ago
Boil Water Notice Issued for New Plymouth Areas Due to E. coli
1h ago